Results 111 to 120 of about 33,112 (265)

Tiotropium Add-On and Treatable Traits in Asthma-COPD Overlap: A Real-World Pilot Study

Journal of Asthma and Allergy, 2022
Yoshihisa Ishiura,1 Masaki Fujimura,2 Noriyuki Ohkura,3 Johsuke Hara,3 Kahori Nakahama,1 Yusuke Sawai,1 Takeshi Tamaki,1 Ryuta Murai,1 Toshiki Shimizu,1 Naoyuki Miyashita,1 Shosaku Nomura1 1First Department of Internal Medicine, Kansai Medical University,
Ishiura Y, Fujimura M, Ohkura N, Hara J, Nakahama K, Sawai Y, Tamaki T, Murai R, Shimizu T, Miyashita N, Nomura S   +10 more
doaj  

P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial: Abstract P122 Table 1 [PDF]

, 2015
Ian Naya, Lee Tombs, Paul Jones
openalex   +1 more source

Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro

, 2022
K. Martens, Emiel Vanhulle, A.-S. Viskens, Peter W. Hellings, Kurt Vermeire   +4 more
openalex   +2 more sources

Onset of Action and Pharmacokinetic Parameters of Azelastine Hydrochloride in Azelastine Nasal Spray and in a Combination Nasal Spray with Fluticasone Propionate [PDF]

, 2009
R. Berkowitz, Susan Braker, L. Fredane, Harry Sacks   +3 more
openalex   +1 more source

Iatrogenic Cushing Syndrome and Secondary Adrenal Insufficiency Due to an Interaction Between Fluticasone and Ritonavir

, 2021
Lorena Suárez Gutiérrez
openalex   +1 more source

24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study [PDF]

, 2020
David A. Lipson, Ruby Birk, Noushin Brealey, Chang‐Qing Zhu   +3 more
openalex   +1 more source

Fluticasone Propionate [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Clinical utility and development of the fluticasone/formoterol combination formulation (Flutiform®) for the treatment of asthma

Drug Design, Development and Therapy, 2014
Ricardo Antonio Tan,1 Jonathan Corren2 1California Allergy and Asthma Medical Group, 2David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Pharmacologic treatment of asthma should be done with a stepwise approach recommended in ...
Tan RA, Corren J
doaj  

Randomized, Open Label, Active Controlled Comparative Study to Assess Safety, Efficacy of Mometasone & Formoterol Versus Fluticasone & Formoterol Dry Powder Inhaler in Treatment of Mild to Moderate Persistent Asthma

National Journal of Community Medicine, 2015
Background: This study conducted to assess and compare the safety and efficacy of Mometasone & Formoterol versus Fluticasone & Formoterol. in patients with mild to moderate persistent asthma on symptom control and rescue medication usage. Method: The
Parasuramalu B G, Sathish Chandra MR, Huliraj N, Giriyanna Gowda, Gangaboraiah   +4 more
doaj  

A cost minimization analysis of Azelastine/Fluticasone combination nasal spray versus Azelastine and Fluticasone nasal sprays monotherapy in moderate to severe allergic rhinitis in Iran

Journal of Pharmacoeconomics and Pharmaceutical Management, 2018
Background: Allergic Rhinitis (AR) is a symptomatic disorder which is due to allergen exposure and IgE inflammatory pathway activation in respiratory tract.
Nayyereh Ayati, Delara Babaie, Shekoufeh Nikfar, Erfan Rohani, Marzieh Nosrati, Pardis Zaboli   +5 more
doaj